Sign inSign in
ConceptMedicine

Eculizumab

A complement C5 monoclonal antibody studied in the PREVENT trial for NMOSD attack prevention.
as Randall Brown defines itUniversity of Louisville
Watch it explained

Know first

Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.

C51Complement pathway1Monoclonal antibodies1Neuromyelitis optica spectrum disorder1

Lecturers

1

    Connections

    2

    The lectures that define it or assume it, and the concepts next to it.

    1 lecturer. Definitions are written by AI from each lecture’s transcript. A time with a play mark starts the lecture at the moment the lecturer says it.